Frequency, distribution and immunologic nature of infusion reactions in subjects receiving pegloticase for chronic refractory gout.

about

Frequency, distribution and immunologic nature of infusion reactions in subjects receiving pegloticase for chronic refractory gout.

Item

http://www.wikidata.org/entity/Q40089636

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Frequency, distribution and im ...... e for chronic refractory gout.

@en

type

Item

label

Frequency, distribution and im ...... e for chronic refractory gout.

@en

prefLabel

Frequency, distribution and im ...... e for chronic refractory gout.

@en

P1476

Frequency, distribution and im ...... e for chronic refractory gout.

@en

P2093

Anthony E Yeo

http://www.w3.org/2001/XMLSchema#string

Arthur Kavanaugh

http://www.w3.org/2001/XMLSchema#string

Leonard H Calabrese

http://www.w3.org/2001/XMLSchema#string

Peter E Lipsky

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials.

Mast cell tryptase: a review of its physiology and clinical significance.

Long-term safety of pegloticase in chronic gout refractory to conventional treatment.

Visual representation of National Institute of Allergy and Infectious Disease and Food Allergy and Anaphylaxis Network criteria for anaphylaxis.

Acute anaphylaxis associated with serum complement depletion.

Prospective Validation of the NIAID/FAAN Criteria for Emergency Department Diagnosis of Anaphylaxis.

Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout.

Evaluation of national institute of allergy and infectious diseases/food allergy and anaphylaxis network criteria for the diagnosis of anaphylaxis in emergency department patients.

Usefulness and limitations of sequential serum tryptase for the diagnosis of anaphylaxis in 102 patients.

P2888

s13075-017-1396-8

P304

191

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13075-017-1396-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091206774

http://www.w3.org/2001/XMLSchema#string

P698

28818095

http://www.w3.org/2001/XMLSchema#string

P932

5561590

http://www.w3.org/2001/XMLSchema#string